We have investigated molecular mechanisms underlying by which AFP-L3 is specifically increased in sera of patients with HCC, but not benign liver diseases although expression of FUT8 in the liver is increased in chronic liver diseases such as chronic hepatitis and liver cirrhosis. This evidence concerns the gene AFP and chronic hepatitis.